APA

Neves S. P., de Carvalho N. C., da Silva M. M., Rodrigues A. C. B. C., Bomfim L. M., Dias R. B., Sales C. B. S., Rocha C. A. G., Soares M. B. P., Batista A. A. & Bezerra D. P. (2019). Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells. : Frontiers in oncology.

Chicago

Neves Sara P, de Carvalho Nanashara C, da Silva Monize M, Rodrigues Ana Carolina B C, Bomfim Larissa M, Dias Rosane B, Sales Caroline B S, Rocha Clarissa A Gurgel, Soares Milena B P, Batista Alzir A and Bezerra Daniel P. 2019. Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells. : Frontiers in oncology.

Harvard

Neves S. P., de Carvalho N. C., da Silva M. M., Rodrigues A. C. B. C., Bomfim L. M., Dias R. B., Sales C. B. S., Rocha C. A. G., Soares M. B. P., Batista A. A. and Bezerra D. P. (2019). Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells. : Frontiers in oncology.

MLA

Neves Sara P, de Carvalho Nanashara C, da Silva Monize M, Rodrigues Ana Carolina B C, Bomfim Larissa M, Dias Rosane B, Sales Caroline B S, Rocha Clarissa A Gurgel, Soares Milena B P, Batista Alzir A and Bezerra Daniel P. Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells. : Frontiers in oncology. 2019.